Increased demand for data on the safety and effectiveness of products in real world settings has lead to an expansion of peri- and post-approval studies (Phase IIIb/IV).

At Elite Research Network, we understand the unique challenges associated with late phase studies. These studies typically require a substantially larger number of patients and can run for over five years. With the majority of our investigators in private practice, we have access to patient populations for the late phase studies we conduct across multiple therapeutic areas. Our patient recruitment departments assist the study teams in order to meet enrolment goals and maximize retention rates, which are critically important due to the length of these studies.

Our peri- and post-approval capabilities include:
  • Comparative Effectiveness Research
  • Health Outcomes
  • Non-interventional, Observational Research
  • Patient Registries
  • Patient-Reported Outcomes Research
  • Safety Surveillance Studies

Contact us to determine if we have the patient population for your study.
Call us: (843) 607-2933  |  email us:  |  follow us:    
Company            Investigator Sites            Therapeutic Expertise            Services            Phase I - IV            Library            News & Events            Contact